NYSEARCA:IBIO - NYSE Arca - US4510337086 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 1.88M -20.68% | -100.00% | 225K | 306K 36.00% | 408K 33.33% | -100.00% | 24.48M | 31.62M 29.17% | 28.56M -9.68% | 36.72M 28.57% | |
EBITDA YoY % growth | -24.67M 14.04% | -27.74M -12.44% | -15.705M 43.39% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
EBIT YoY % growth | -27.94M 10.19% | -28.77M -2.97% | -16.634M 42.18% | -16.604M 0.18% | -18.87M -13.65% | -23.358M -23.78% | -3.06M 86.90% | -1.02M 66.67% | -4.08M -300.00% | 3.06M 175.00% | |
Operating Margin | -1,486.17% | N/A | -7,392.89% | -5,426.00% | -4,625.00% | N/A | -12.50% | -3.23% | -14.29% | 8.33% | |
EPS YoY % growth | -5.71 -73.03% | -11.27 -97.37% | N/A 32.94% | -1.62 78.54% | -1.40 13.52% | -0.68 51.27% | -0.05 92.54% | 0.08 260.00% | -0.06 -175.00% | 0.29 566.67% |
All data in USD
Q2 / 25 | Q3 / 25 | Q4 / 25 | |
---|---|---|---|
EPS Q2Q % growth | -0.47 | -0.33 54.03% | -0.35 61.72% |
Revenue Q2Q % growth | -100.00% | ||
EBITDA Q2Q % growth | N/A | N/A | N/A |
EBIT Q2Q % growth | -4.131M 8.12% | -3.902M -7.60% | -4.131M -21.18% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2025 Q2Q % growth | -0.46 | -0.49 | 0.03 | 6.05% |
Q4 2024 Q2Q % growth | -0.91 -117.42% | -0.48 | -0.43 | -88.99% |
Q3 2024 Q2Q % growth | -0.71 93.55% | % | ||
Q4 2023 Q2Q % growth | 5.20 365.31% | -8.36 | 13.56 | 162.17% |
Q3 2023 Q2Q % growth | -11.00 -633.33% | -7.34 | -3.66 | -49.78% |
Q2 2023 Q2Q % growth | -3.42 -173.60% | -2.03 | -1.39 | -68.49% |
Q1 2023 Q2Q % growth | -2.05 -105.00% | -1.89 | -0.16 | -8.35% |
Q4 2022 Q2Q % growth | -1.96 -3,820.00% | -2.17 | 0.21 | 9.57% |
Q3 2022 Q2Q % growth | -1.50 -50.00% | -1.40 | -0.10 | -6.95% |
Q2 2022 Q2Q % growth | -1.25 -25.00% | -1.02 | -0.23 | -22.55% |
Q1 2022 Q2Q % growth | -1.00 20.00% | -1.28 | 0.27 | 21.57% |
Q4 2021 Q2Q % growth | -0.05 96.08% | % | ||
Q3 2021 Q2Q % growth | -1.00 | -1.28 | 0.27 | 21.57% |
Q2 2021 Q2Q % growth | -1.00 21.57% | -1.02 | 0.02 | 1.96% |
Q1 2021 Q2Q % growth | -1.25 | -2.04 | 0.79 | 38.73% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2025 Q2Q % growth | -100.00% | % | ||
Q4 2023 Q2Q % growth | 204K | -204K | -100.00% | |
Q3 2023 Q2Q % growth | -100.00% | 204K | -204K | -100.00% |
Q2 2023 Q2Q % growth | 510K | -510K | -100.00% | |
Q1 2023 Q2Q % growth | -100.00% | 612K | -612K | -100.00% |
Q4 2022 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
Q3 2022 Q2Q % growth | 1.8M 133.77% | 204K | 1.596M | 782.35% |
Q2 2022 Q2Q % growth | -100.00% | 255K | -255K | -100.00% |
Q1 2022 Q2Q % growth | 80K -80.49% | 510K | -430K | -84.31% |
Q4 2021 Q2Q % growth | 490K -56.25% | % | ||
Q3 2021 Q2Q % growth | 770K 670.00% | 816K | -46K | -5.64% |
Q2 2021 Q2Q % growth | 710K 129.03% | 510K | 200K | 39.22% |
Q1 2021 Q2Q % growth | 410K 272.73% | 410K | % | |
Q4 2020 Q2Q % growth | 1.12M 40.00% | 102K | 1.018M | 998.04% |
Q3 2020 Q2Q % growth | 100K -81.13% | % | ||
Q2 2020 Q2Q % growth | 310K -52.31% | 102K | 208K | 203.92% |
Q1 2020 Q2Q % growth | 110K 120.00% | % |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | -4.55% | -4.55% | 10.42% | 10.42% |
Revenue | N/A | N/A | N/A | N/A |